Tibial Fractures

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
1 program
1
InductOsPhase 41 trial
Active Trials
NCT00161616Completed277Est. Aug 2008
Bioventus
BioventusDURHAM, NC
1 program
Exogen 4000+N/A1 trial
Active Trials
NCT00667849Terminated501Est. Dec 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
PfizerInductOs
BioventusExogen 4000+

Clinical Trials (2)

Total enrollment: 778 patients across 2 trials

Study Evaluating InductOs in Diaphyseal Tibia Fractures

Start: Sep 2003Est. completion: Aug 2008277 patients
Phase 4Completed

Trial to Evaluate UltraSound in the Treatment of Tibial Fractures

Start: Sep 2008Est. completion: Dec 2012501 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space